Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Sheng-Kai LiangChang-Wei WuChing-I ChangLi-Ta KengMeng-Rui LeeJann-Yuan WangJen-Chung KoWei-Yu LiaoKuan-Yu ChenChao-Chi HoJin-Yuan ShihChong-Jen YuPublished in: Cancer medicine (2023)
This population-based study in the real-world setting of Taiwan demonstrates comparable effectiveness between oral UFT and intravenous chemotherapy in terms of clinical outcomes for early-stage NSCLC patients after surgery.
Keyphrases
- early stage
- end stage renal disease
- prognostic factors
- high dose
- ejection fraction
- small cell lung cancer
- chronic kidney disease
- sentinel lymph node
- randomized controlled trial
- newly diagnosed
- locally advanced
- peritoneal dialysis
- single cell
- lymph node
- stem cells
- cell therapy
- low dose
- radiation therapy
- chemotherapy induced
- tyrosine kinase